Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ABIVAX Société AnonymeCOMM(ABVX) | 6,007,834 | 3,663,038 | -2,344,796 | $800.60M | $362.71M | 10.25% | -$437.89M |
| CG Oncology, Inc.COMM(CGON) | 3,670,206 | 3,670,206 | 0 | $260.77M | $260.18M | 7.35% | -$587.2K |
| Amylyx Pharmaceuticals, Inc.COMM(AMLX) | 6,243,812 | 6,243,812 | 0 | $112.14M | $181.69M | 5.13% | +$69.56M |
| Spyre Therapeutics, Inc.COMM(SYRE) | 1,900,582 | 1,900,582 | 0 | $168.73M | $169.21M | 4.78% | +$475.1K |
| Tango Therapeutics, Inc.COMM(TNGX) | 9,081,201 | 6,773,043 | -2,308,158 | $283.88M | $168.99M | 4.77% | -$114.89M |
| Zai Lab LimitedADRS(ZLAB) | 6,137,627 | 6,229,081 | +91,454 | $116.61M | $164.07M | 4.64% | +$47.46M |
| Immunovant, Inc.COMM(IMVT) | 4,457,988 | 4,457,988 | 0 | $171.77M | $150.59M | 4.25% | -$21.18M |
| Dianthus Therapeutics, Inc.COMM(DNTH) | 1,676,624 | 1,676,624 | 0 | $163.44M | $147.63M | 4.17% | -$15.81M |
| Korsana Biosciences IncCOMM | 0 | 4,549,587 | +4,549,587 | $0 | $145.59M | 4.11% | +$145.59M |
| Kodiak Sciences Inc.COMM(KOD) | 1,445,538 | 1,445,538 | 0 | $56.32M | $137.04M | 3.87% | +$80.72M |
| Vor Biopharma Inc.COMM(VOR) | 5,673,078 | 5,673,078 | 0 | $104.44M | $108.24M | 3.06% | +$3.80M |
| First Tracks BiotherapeuticsCOMM | 2,895,304 | 2,895,304 | 0 | $58.25M | $102.61M | 2.90% | +$44.36M |
| Mirum Pharmaceuticals, Inc.COMM(MIRM) | 1,062,049 | 1,118,967 | +56,918 | $124.33M | $95.65M | 2.70% | -$28.68M |
| BioCryst Pharmaceuticals, Inc.COMM(BCRX) | 11,020,968 | 11,020,968 | 0 | $110.21M | $91.80M | 2.59% | -$18.41M |
| Disc Medicine, Inc.COMM(IRON) | 1,341,862 | 1,341,862 | 0 | $98.14M | $87.84M | 2.48% | -$10.31M |
| Adarx Pharmaceuticals IncCOMM | 0 | 4,116,452 | +4,116,452 | $0 | $82.08M | 2.32% | +$82.08M |
| Cogent Biosciences, Inc.COMM(COGT) | 4,854,436 | 2,500,003 | -2,354,433 | $187.87M | $80.05M | 2.26% | -$107.82M |
| Tyra Biosciences, Inc.COMM(TYRA) | 3,248,980 | 3,475,980 | +227,000 | $103.77M | $76.02M | 2.15% | -$27.75M |
| Dyne Therapeutics, Inc.COMM(DYN) | 4,615,144 | 4,615,144 | 0 | $102.50M | $74.35M | 2.10% | -$28.15M |
| Relay Therapeutics, Inc.COMM(RLAY) | 4,273,356 | 3,783,529 | -489,827 | $79.95M | $68.29M | 1.93% | -$11.66M |
| Aura Biosciences, Inc.COMM(AURA) | 9,533,333 | 10,165,357 | +632,024 | $67.69M | $63.84M | 1.80% | -$3.85M |
| Savara Inc.COMM(SVRA) | 12,362,205 | 12,362,205 | 0 | $76.15M | $63.79M | 1.80% | -$12.36M |
| Xencor, Inc.COMM(XNCR) | 2,452,138 | 2,055,938 | -396,200 | $39.48M | $51.30M | 1.45% | +$11.82M |
| Avalo Therapeutics, Inc.COMM(AVTX) | 3,017,120 | 3,017,120 | 0 | $55.76M | $46.25M | 1.31% | -$9.50M |
| Monte Rosa Therapeutics, Inc.COMM(GLUE) | 4,622,151 | 3,781,532 | -840,619 | $111.86M | $45.11M | 1.27% | -$66.74M |
| MBX Biosciences, Inc.COMM(MBX) | 650,000 | 650,000 | 0 | $35.88M | $38.10M | 1.08% | +$2.22M |
| Entera Bio Ltd.COMM(ENTX) | 0 | 12,254,901 | +12,254,901 | $0 | $35.66M | 1.01% | +$35.66M |
| Janux Therapeutics, Inc.COMM(JANX) | 1,789,617 | 1,789,617 | 0 | $27.49M | $30.92M | 0.87% | +$3.44M |
| Tarsus Pharmaceuticals, Inc.COMM(TARS) | 0 | 388,164 | +388,164 | $0 | $30.51M | 0.86% | +$30.51M |
| Century Therapeutics, Inc.COMM(IPSC) | 17,754,430 | 17,754,430 | 0 | $43.40M | $30.36M | 0.86% | -$13.04M |
| Obsidian Therapeutics IncCOMM | 0 | 2,196,138 | +2,196,138 | $0 | $30.15M | 0.85% | +$30.15M |
| Pharvaris BvCOMM COM | 1,008,229 | 947,544 | -60,685 | $34.86M | $30.06M | 0.85% | -$4.81M |
| LB Pharmaceuticals IncCOMM(LBRX) | 1,447,310 | 765,050 | -682,260 | $46.97M | $29.36M | 0.83% | -$17.61M |
| Editas Medicine, Inc.COMM(EDIT) | 11,111,111 | 11,111,111 | 0 | $36.00M | $28.56M | 0.81% | -$7.44M |
| Tectonic Therapeutic, Inc.COMM(TECX) | 1,204,891 | 1,204,891 | 0 | $41.42M | $28.06M | 0.79% | -$13.36M |
| InflaRx N.V.COMM(IFRX) | 14,500,000 | 14,500,000 | 0 | $32.48M | $26.10M | 0.74% | -$6.38M |
| Perspective Therapeutics, Inc.COMM(CATX) | 7,915,567 | 7,915,567 | 0 | $26.99M | $21.77M | 0.61% | -$5.22M |
| AgomAb Therapeutics NVADRS(AGMB) | 2,053,233 | 1,820,831 | -232,402 | $26.65M | $20.21M | 0.57% | -$6.44M |
| Silence Therapeutics plcADRS(SLN) | 3,033,560 | 1,819,035 | -1,214,525 | $33.31M | $19.88M | 0.56% | -$13.43M |
| Alector IncCOMM | 10,000,000 | 10,000,000 | 0 | $20.10M | $18.50M | 0.52% | -$1.60M |
| Biohaven Ltd.COMM(BHVN) | 1,779,952 | 1,262,423 | -517,529 | $26.49M | $16.85M | 0.48% | -$9.63M |
| Monopar Therapeutics Inc.COMM(MNPR) | 203,327 | 202,242 | -1,085 | $18.83M | $16.11M | 0.46% | -$2.71M |
| ADC Therapeutics SACOMM(ADCT) | 11,390,175 | 11,390,175 | 0 | $12.19M | $13.90M | 0.39% | +$1.71M |
| Entrada Therapeutics, Inc.COMM(TRDA) | 1,060,230 | 1,060,230 | 0 | $7.80M | $6.73M | 0.19% | -$1.07M |
| Cullinan Therapeutics, Inc.COMM(CGEM) | 406,786 | 406,786 | 0 | $7.41M | $6.24M | 0.18% | -$1.16M |
| Agenus Inc.COMM(AGEN) | 0 | 603,892 | +603,892 | $0 | $6.00M | 0.17% | +$6.00M |
| Ocular Therapeutix, Inc.COMM(OCUL) | 1,647,752 | 720,323 | -927,429 | $16.18M | $5.52M | 0.16% | -$10.66M |
| Arvinas, Inc.COMM(ARVN) | 707,098 | 707,098 | 0 | $5.88M | $5.47M | 0.15% | -$406.6K |
| Korro Bio, Inc.COMM(KRRO) | 416,301 | 416,301 | 0 | $5.49M | $4.13M | 0.12% | -$1.36M |
| Research Alliance Corp Iv-ACOMM | 0 | 300,000 | +300,000 | $0 | $3.60M | 0.10% | +$3.60M |
| ALX Oncology Holdings Inc.COMM(ALXO) | 5,655,487 | 2,465,436 | -3,190,051 | $11.71M | $3.43M | 0.10% | -$8.28M |
| Aktis Oncology, Inc.COMM(AKTS) | 696,560 | 133,457 | -563,103 | $22.45M | $2.60M | 0.07% | -$19.85M |
| Jatt Ii Acquisition CorpCOMM | 200,000 | 200,000 | 0 | $2.27M | $2.25M | 0.06% | -$23.0K |
| LeonaBio, Inc.COMM(LONA) | 464,398 | 464,398 | 0 | $4.27M | $1.66M | 0.05% | -$2.61M |
| Jatt Iii Acquisition CorpCOMM | 0 | 100,000 | +100,000 | $0 | $1.10M | 0.03% | +$1.10M |
| Context Therapeutics Inc.COMM(CNTX) | 2,682,696 | 2,682,696 | 0 | $1.49M | $805.9K | 0.02% | -$680.1K |
| Eikon Therapeutics, Inc.COMM(EIKN) | 37,902 | 37,902 | 0 | $494.6K | $304.7K | 0.01% | -$189.9K |
| Altimmune, Inc.COMM(ALT) | 10,000,000 | 0 | -10,000,000 | $30.40M | $0 | — | -$30.40M |
| Forte Biosciences IncCOMM | 920,000 | 0 | -920,000 | $19.55M | $0 | — | -$19.55M |
| Research Alliance Corp Cl ACOMM | 500,000 | 0 | -500,000 | $5.35M | $0 | — | -$5.35M |
| Revolution Medicines, Inc.COMM(RVMD) | 340,899 | 0 | -340,899 | $63.84M | $0 | — | -$63.84M |
| Surrozen, Inc.COMM(SRZN) | 1,473,101 | 0 | -1,473,101 | $38.23M | $0 | — | -$38.23M |